Published in J Clin Microbiol on April 01, 1996
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev (1996) 13.91
Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev (1998) 5.33
The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev (2010) 4.22
Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in comparison to 16S rRNA gene sequencing for species identification of nonfermenting bacteria. J Clin Microbiol (2008) 4.18
Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol (2001) 4.02
Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov. J Clin Microbiol (2002) 3.44
Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium. J Clin Microbiol (1997) 3.33
16S rRNA gene sequencing versus the API 20 NE system and the VITEK 2 ID-GNB card for identification of nonfermenting Gram-negative bacteria in the clinical laboratory. J Clin Microbiol (2006) 3.25
Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients. J Clin Microbiol (1999) 3.19
Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates. J Clin Microbiol (1999) 2.87
Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis. Thorax (2007) 2.60
Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods. J Clin Microbiol (1999) 2.36
PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients. J Clin Microbiol (2004) 2.31
Comparative evaluation of the BD Phoenix and VITEK 2 automated instruments for identification of isolates of the Burkholderia cepacia complex. J Clin Microbiol (2002) 2.16
Identification of Pandoraea species by 16S ribosomal DNA-based PCR assays. J Clin Microbiol (2001) 2.09
Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex. J Clin Microbiol (2001) 2.06
Identification and detection of Stenotrophomonas maltophilia by rRNA-directed PCR. J Clin Microbiol (2000) 1.90
Infection by Ralstonia species in cystic fibrosis patients: identification of R. pickettii and R. mannitolilytica by polymerase chain reaction. Emerg Infect Dis (2002) 1.88
Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture. J Clin Microbiol (2000) 1.82
Species-specific PCR as a tool for the identification of Burkholderia gladioli. J Clin Microbiol (2000) 1.65
Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and IV by PCR. J Clin Microbiol (1999) 1.43
Optimization of routine identification of clinically relevant Gram-negative bacteria by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry and the Bruker Biotyper. J Clin Microbiol (2013) 1.42
Use of real-time PCR with multiple targets to identify Pseudomonas aeruginosa and other nonfermenting gram-negative bacilli from patients with cystic fibrosis. J Clin Microbiol (2003) 1.40
Superiority of molecular techniques for identification of gram-negative, oxidase-positive rods, including morphologically nontypical Pseudomonas aeruginosa, from patients with cystic fibrosis. J Clin Microbiol (2005) 1.39
Preliminary evaluation of the API 20NE and RapID NF plus systems for rapid identification of Burkholderia pseudomallei and B. mallei. J Clin Microbiol (2005) 1.31
Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers. J Clin Microbiol (1997) 1.29
Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol (1999) 1.21
Manual and automated instrumentation for identification of Enterobacteriaceae and other aerobic gram-negative bacilli. Clin Microbiol Rev (2005) 1.20
Acinetobacter septicus sp. nov. association with a nosocomial outbreak of bacteremia in a neonatal intensive care unit. J Clin Microbiol (2007) 1.20
Direct comparison of the BD phoenix system with the MicroScan WalkAway system for identification and antimicrobial susceptibility testing of Enterobacteriaceae and nonfermentative gram-negative organisms. J Clin Microbiol (2008) 1.14
PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients. J Clin Microbiol (2001) 1.10
Capillary electrophoresis-single-strand conformation polymorphism analysis for rapid identification of Pseudomonas aeruginosa and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol (1999) 1.08
Biochemical and susceptibility tests useful for identification of nonfermenting gram-negative rods. J Clin Microbiol (2002) 1.06
Evaluation of MicroScan Autoscan for identification of Pseudomonas aeruginosa isolates from cystic fibrosis patients. J Clin Microbiol (2003) 1.06
Outbreak of Corynebacterium pseudodiphtheriticum infection in cystic fibrosis patients, France. Emerg Infect Dis (2010) 1.00
Low rates of Pseudomonas aeruginosa misidentification in isolates from cystic fibrosis patients. J Clin Microbiol (2009) 0.95
Burkholderia glumae infection in an infant with chronic granulomatous disease. J Clin Microbiol (2006) 0.93
Compliance of clinical microbiology laboratories in the United States with current recommendations for processing respiratory tract specimens from patients with cystic fibrosis. J Clin Microbiol (2006) 0.91
First isolation of two colistin-resistant emerging pathogens, Brevundimonas diminuta and Ochrobactrum anthropi, in a woman with cystic fibrosis: a case report. J Med Case Rep (2008) 0.87
Ochrobactrum anthropi misidentified as Shewanella putrefaciens. J Clin Microbiol (2003) 0.84
Identification of potential diagnostic markers among Burkholderia cenocepacia and B. multivorans supernatants. J Clin Microbiol (2010) 0.80
Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev (1991) 7.12
Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet (1993) 7.12
Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med (1994) 3.89
Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol (1985) 3.09
Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis. J Clin Microbiol (1987) 2.59
Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. Chest (1993) 2.58
Comparison of the autoSCAN-W/A rapid bacterial identification system and the Vitek AutoMicrobic system for identification of gram-negative bacilli. J Clin Microbiol (1991) 2.51
Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis. J Clin Microbiol (1989) 2.15
Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission. J Clin Microbiol (1993) 2.12
Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis. Am Rev Respir Dis (1986) 2.10
Four methods for identification of gram-negative nonfermenting rods: organisms more commonly encountered in clinical specimens. J Clin Microbiol (1980) 2.09
Evaluation of the rapid NFT system for identification of gram-negative, nonfermenting rods. J Clin Microbiol (1984) 1.78
Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients. J Clin Epidemiol (1990) 1.69
Critical evaluation of the AutoMicrobic system gram-negative identification card for identification of glucose-nonfermenting gram-negative rods. J Clin Microbiol (1986) 1.65
Comparison of the autoSCAN-W/A and Vitek Automicrobic systems for identification and susceptibility testing of bacteria. Eur J Clin Microbiol Infect Dis (1992) 1.63
A comparison of four commercial systems for the identification of nonfermentative gram-negative bacilli. Am J Clin Pathol (1980) 1.37
Evaluation of the AutoMicrobic system for identification of glucose-nonfermenting gram-negative rods. J Clin Microbiol (1982) 1.30
Post-transplantation survival of cystic fibrosis patients infected with Pseudomonas cepacia. Lancet (1994) 1.22
Evaluation of pertinent parameters of a new identification system for non-enteric gram-negative rods. Eur J Clin Microbiol (1985) 1.05
Comparison of antibody reactivity to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in sera from HIV-1-infected individuals from Tanzania and from the United States. J Clin Microbiol (1992) 0.98
The origin of mutants. Nature (1988) 8.92
Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science (1990) 8.07
Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med (1987) 7.82
Kidney transplantation under FK 506. JAMA (1990) 7.45
Medical student selection: a tentative attempt to establish a code of practice. Br Med J (1980) 7.21
Agrobacterium conjugation and gene regulation by N-acyl-L-homoserine lactones. Nature (1993) 6.55
Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol (1988) 5.71
Lymphocyte transformation in vitro measured by tritiated thymidine uptake. I. Lymphocyte culture techniques. Int Arch Allergy Appl Immunol (1970) 5.67
Surface, subunit interfaces and interior of oligomeric proteins. J Mol Biol (1988) 4.80
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science (2000) 4.48
Virulence of antibiotic-resistant Salmonella typhimurium. Proc Natl Acad Sci U S A (1998) 4.28
Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr (1985) 4.26
Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA (2001) 4.26
The time course of minimal excitory post-synaptic potentials evoked in spinal motoneurones by group Ia afferent fibres. J Physiol (1971) 3.93
Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature (1991) 3.86
Consultation length and outcome in two group general practices. J R Coll Gen Pract (1983) 3.76
Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome. Am J Med Genet (1992) 3.74
Excitation of the corticospinal tract by electromagnetic and electrical stimulation of the scalp in the macaque monkey. J Physiol (1990) 3.66
Brief report: fulminating fat embolism syndrome caused by paradoxical embolism through a patent foramen ovale. N Engl J Med (1993) 3.55
Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31
Transfer of virulence in vivo and in vitro in Agrobacterium. Nature (1977) 3.23
Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol (1985) 3.09
A revision of Rhizobium Frank 1889, with an emended description of the genus, and the inclusion of all species of Agrobacterium Conn 1942 and Allorhizobium undicola de Lajudie et al. 1998 as new combinations: Rhizobium radiobacter, R. rhizogenes, R. rubi, R. undicola and R. vitis. Int J Syst Evol Microbiol (2001) 2.97
Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus. Mol Microbiol (2001) 2.94
East pacific rise: hot springs and geophysical experiments. Science (1980) 2.94
The accessible surface area and stability of oligomeric proteins. Nature (1987) 2.77
Host cellular immune response to pneumococcal lung infection in mice. Infect Immun (2000) 2.74
The gap between patient reading comprehension and the readability of patient education materials. J Fam Pract (1990) 2.68
Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis. J Clin Microbiol (1987) 2.59
Postexposure prophylaxis after nonoccupational HIV exposure: clinical, ethical, and policy considerations. JAMA (1998) 2.58
Paper and people: the work of the casualty reception clerk. Sociol Health Illn (1989) 2.54
Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry (1996) 2.49
Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst (1995) 2.45
The DNA sequence and biological annotation of human chromosome 1. Nature (2006) 2.42
Serological studies on infections by respiratory viruses of the inhabitants of Tristan da Cunha. J Hyg (Lond) (1967) 2.42
Crystal structure of P22 tailspike protein: interdigitated subunits in a thermostable trimer. Science (1994) 2.41
Acquired perforating dermatosis in a British dialysis population. Br J Dermatol (1996) 2.40
Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol (1997) 2.37
Neurobiological basis of speech: a case for the preeminence of temporal processing. Ann N Y Acad Sci (1993) 2.35
Prospective analysis of stoma-related complications. Colorectal Dis (2005) 2.35
Post-traumatic stress disorder in the community: an epidemiological study. Psychol Med (1991) 2.34
Evidence of activity-dependent withdrawal of corticospinal projections during human development. Neurology (2001) 2.32
Transmission of multidrug-resistant serotype 23F Streptococcus pneumoniae in group day care: evidence suggesting capsular transformation of the resistant strain in vivo. J Infect Dis (1995) 2.31
Disappointing sensitivity of endoscopic markers for villous atrophy in a high-risk population: implications for celiac disease diagnosis during routine endoscopy. Am J Gastroenterol (2001) 2.30
FK 506 in clinical kidney transplantation. Transplant Proc (1991) 2.29
Homeostasis of alpha beta TCR+ T cells. Nat Immunol (2000) 2.29
The macrophage scavenger receptor type A is expressed by activated macrophages and protects the host against lethal endotoxic shock. J Exp Med (1997) 2.28
A gender-specific HIV/STD risk reduction intervention for women in a health care setting: short- and long-term results of a randomized clinical trial. AIDS Care (2002) 2.28
Nontuberculous mycobacteria in adult patients with cystic fibrosis. Chest (1992) 2.25
Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol (1993) 2.22
Evaluation of mental retardation: recommendations of a Consensus Conference: American College of Medical Genetics. Am J Med Genet (1997) 2.19
Transduction and rearrangement of the myc gene by feline leukaemia virus in naturally occurring T-cell leukaemias. Nature (1984) 2.14
Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J Infect Dis (1997) 2.09
A simple genetic basis for a complex psychological trait in laboratory mice. Science (1995) 2.06
Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature (1993) 2.04
HIV/AIDS and maternity care in Kenya: how fears of stigma and discrimination affect uptake and provision of labor and delivery services. AIDS Care (2008) 2.04
RCPE UK consensus statement on diabetes. J R Coll Physicians Edinb (2010) 2.03
The breast radiation injury litigation and the clinical oncologist. Clin Oncol (R Coll Radiol) (1998) 2.03
Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J Virol (1995) 2.01
Interstitial and terminal deletions of the long arm of chromosome 4: further delineation of phenotypes. Am J Med Genet (1988) 2.00
Periventricular heterotopia: phenotypic heterogeneity and correlation with Filamin A mutations. Brain (2006) 2.00
Prospective observational cohort study of time saved by prehospital thrombolysis for ST elevation myocardial infarction delivered by paramedics. BMJ (2003) 1.99
Unexpected complexity in the haplotypes of commonly used inbred strains of laboratory mice. Proc Natl Acad Sci U S A (2004) 1.99
Artificial dermis for major burns. A multi-center randomized clinical trial. Ann Surg (1988) 1.98
Comparison of sevoflurane and propofol with rocuronium for modified rapid-sequence induction of anaesthesia. Anaesthesia (1999) 1.98
Cognitive functioning and brain magnetic resonance imaging in children with sickle Cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease. Pediatrics (1996) 1.98
Macrosomia--maternal characteristics and infant complications. Obstet Gynecol (1985) 1.96
Prevalence of celiac disease and its endoscopic markers among patients having routine upper gastrointestinal endoscopy. Am J Gastroenterol (1999) 1.93
Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation (1999) 1.93
Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr (1996) 1.90
Role of genetic resistance in invasive pneumococcal infection: identification and study of susceptibility and resistance in inbred mouse strains. Infect Immun (2001) 1.86
Relationship between atmospheric temperature and survival of airborne bacteria. Appl Microbiol (1970) 1.84
Arginine catabolism: a new function of both octopine and nopaline Ti-plasmids of Agrobacterium. Mol Gen Genet (1979) 1.84
Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis. J Clin Microbiol (1987) 1.80
Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc Natl Acad Sci U S A (1997) 1.80
Climate change and the integrity of science. Science (2010) 1.80
Detection of a noble gas molecular ion, 36ArH+, in the Crab Nebula. Science (2013) 1.80
Structure of a mutant EF-G reveals domain III and possibly the fusidic acid binding site. J Mol Biol (2000) 1.78
Biotype of Haemophilus influenzae: correlation with virulence and ampicillin resistance. J Infect Dis (1983) 1.78
Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammals. Mol Cell Biol (1999) 1.77
Novel ribosomal mutations affecting translational accuracy, antibiotic resistance and virulence of Salmonella typhimurium. Mol Microbiol (1999) 1.75
Macrophage recruitment during limb development and wound healing in the embryonic and foetal mouse. J Cell Sci (1994) 1.74
A selective medium for Agrobacterium radiobacter biotype 2. J Appl Bacteriol (1971) 1.74
Fusidic acid-resistant mutants define three regions in elongation factor G of Salmonella typhimurium. Gene (1994) 1.74
Lateral spine radiographs before androgen deprivation treatment detect a high incidence of undiagnosed vertebral fragility fractures in men with advanced prostate cancer. J Urol (2011) 1.72
Importance of culture in laboratory diagnosis of Bordetella pertussis infections. J Clin Microbiol (1984) 1.70
Communication in locked-in syndrome: effects of imagery on salivary pH. Neurology (2006) 1.70
Bolus dose remifentanil for control of haemodynamic response to tracheal intubation during rapid sequence induction of anaesthesia. Br J Anaesth (1999) 1.69
Crystal structure of phage P22 tailspike protein complexed with Salmonella sp. O-antigen receptors. Proc Natl Acad Sci U S A (1996) 1.66
Head injuries: a study evaluating the impact of the NICE head injury guidelines. Emerg Med J (2005) 1.66
The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood (1998) 1.66
Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. J Med Genet (2005) 1.63
Muller's ratchet decreases fitness of a DNA-based microbe. Proc Natl Acad Sci U S A (1996) 1.63
Isolation of Yersinia enterocolitica from milk and a dairy farm in Australia. J Appl Bacteriol (1979) 1.63
Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials. Biochem J (1999) 1.62